Expertise in
9
conditions

Dr. John F. Kingrey

Pulmonary Medicine
INTEGRIS Baptist Medical Center
3300 NW Expressway, 
Oklahoma City, OK 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
9
conditions
INTEGRIS Baptist Medical Center
3300 NW Expressway, 
Oklahoma City, OK 

Overview

John Kingrey is a Pulmonary Medicine provider practicing medicine in Oklahoma City, Oklahoma.

Dr. Kingrey is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Endoscopy, and Advanced Bronchoscopy.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 9 clinical trials. Dr. Kingrey is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in OH

Hospital Affiliations

Integris Health Edmond Hospital
Integris Baptist Medical Center, Inc
Ascension St John Medical Center
Jackson County Memorial Hospital Authority
Washington Regional Medical Center

Languages Spoken

English
French

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

GlobalHealth
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

INTEGRIS Baptist Medical Center
3300 NW Expressway, Oklahoma City, OK 73112
Other Locations
Office
3400 NW Expressway Ste 300, Oklahoma City, OK 73112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
Enrollment Status: Terminated
Publish Date: February 22, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
View 8 Less Clinical Trials

12 Total Publications

Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations.
Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations.
Journal: CHEST pulmonary
Published: August 04, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Dennis M. Parker
Pulmonary Medicine
Expertise in
21
conditions
Dr. Dennis M. Parker
Pulmonary Medicine
Referral may be required
Before you request

Nancy Satzler MD PC

3366 NW Expressway Ste 660, 
Oklahoma City, OK 
 (0.2 miles away)
405-947-3345
Languages Spoken:
English, French, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Dennis Parker is a Pulmonary Medicine provider practicing medicine in Oklahoma City, Oklahoma. Dr. Parker is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Pleural Effusion. Dr. Parker is currently accepting new patients.

Expertise in
31
conditions
Dr. Eva Sawheny
Pulmonary Medicine
Expertise in
31
conditions
Dr. Eva Sawheny
Pulmonary Medicine
Referral may be required
Before you request
1000 N. Lee Ave., 
Oklahoma City, OK 
 (4.6 miles away)
405-772-4400
Languages Spoken:
English, Hungarian
See accepted insurances
Accepting New Patients

Eva Sawheny is a Pulmonary Medicine provider practicing medicine in Oklahoma City, Oklahoma. Dr. Sawheny is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Lung Metastases, Obstructive Sleep Apnea, Gastrostomy, and Advanced Bronchoscopy. Dr. Sawheny is board certified in American Board Of Internal Medicine/Pulmonary Disease , American Board Of Internal Medicine/Critical Care Medicine , American Board Of Internal Medicine/Sleep Medicine , Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Sawheny is currently accepting new patients.

Expertise in
15
conditions
Dr. Azhar U. Khan
Pulmonary Medicine
Expertise in
15
conditions
Dr. Azhar U. Khan
Pulmonary Medicine
Referral may be required
Before you request

Nancy Satzler MD PC

3366 NW Expressway Ste 660, 
Oklahoma City, OK 
 (0.2 miles away)
405-947-3347
Experience:
44+ years
Languages Spoken:
English, French, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Azhar Khan is a Pulmonary Medicine provider practicing medicine in Oklahoma City, Oklahoma. He has been practicing medicine for over 44 years. Dr. Khan is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Gastrostomy, and Hip Replacement. Dr. Khan is currently accepting new patients.

Frequently Asked Questions about Dr. John F. Kingrey

How do I make an appointment with Dr. John F. Kingrey?

You can book an appointment with Dr. John F. Kingrey by calling their office at 405-949-3349. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John F. Kingrey a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John F. Kingrey is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John F. Kingrey specialize in?

While Dr. John F. Kingrey is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. John F. Kingrey participate in research or clinical trials?

Yes. Dr. John F. Kingrey has published 12 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. John F. Kingrey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John F. Kingrey accept my insurance?

Dr. John F. Kingrey accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 405-949-3349 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kingrey's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile